ACHIEVE LIFE SCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Achieve Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2024.
  • Achieve Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$12.4M, a 126% decline year-over-year.
  • Achieve Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$39.8M, a 33.6% decline year-over-year.
  • Achieve Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$39.8M, a 33.6% decline from 2023.
  • Achieve Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.8M, a 29.6% increase from 2022.
  • Achieve Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.4M, a 27.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$39.8M -$12.4M -$6.88M -126% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 -$32.9M -$12.5M -$5.4M -76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$27.5M -$8.46M -$222K -2.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$27.3M -$6.49M +$2.5M +27.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$29.8M -$5.48M +$5.76M +51.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 -$35.6M -$7.11M +$5.97M +45.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$41.5M -$8.24M +$2.23M +21.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$43.8M -$8.99M -$1.42M -18.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$42.4M -$11.2M -$4.08M -57.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-11
Q3 2022 -$38.3M -$13.1M -$6.39M -95.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$31.9M -$10.5M +$843K +7.45% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$32.7M -$7.57M +$426K +5.33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$33.2M -$7.15M -$2.43M -51.4% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-10
Q3 2021 -$30.7M -$6.69M -$2.93M -77.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$27.8M -$11.3M -$8.39M -287% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$19.4M -$8M -$4.68M -141% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$14.7M -$4.72M -$1.53M -47.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$13.2M -$3.76M -$91K -2.48% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-10
Q2 2020 -$13.1M -$2.92M +$702K +19.4% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-10
Q1 2020 -$13.8M -$3.32M +$2.58M +43.8% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-10
Q4 2019 -$16.4M -$3.19M +$443K +12.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$16.8M -$3.67M -$433K -13.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$16.4M -$3.62M -$836K -30% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$15.6M -$5.9M -$2.88M -95.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$12.7M -$3.64M +$103K +2.75% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$12.8M -$3.24M +$3.23M +49.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-13
Q2 2018 -$16M -$2.79M -$2.62M -1550% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-13
Q1 2018 -$13.4M -$3.02M -$2.82M -1374% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-13
Q4 2017 -$10.6M -$3.74M -$3.25M -670% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$7.33M -$6.47M -$6.2M -2314% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$1.13M -$169K +$69K +29% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$1.2M -$205K +$37K +15.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$1.23M -$486K +$1.24M +71.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$2.47M -$268K +$4.28M +94.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$6.75M -$238K +$5.77M +96% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$12.5M -$242K +$4.28M +94.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$16.8M -$1.72M +$3.96M +69.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$20.8M -$4.55M +$357K +7.28% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$21.1M -$6.01M +$1.01M +14.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$22.1M -$4.52M +$4.12M +47.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 -$26.2M -$5.68M +$996K +14.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$27.2M -$4.91M +$5.15M +51.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$32.4M -$7.02M +$1.41M +16.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$33.8M -$8.64M -$1.94M -29% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$31.8M -$6.68M -$2.58M -62.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$29.3M -$10.1M -$4.13M -69.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-26
Q2 2013 -$25.1M -$8.42M -$4.21M -99.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-26
Q1 2013 -$20.9M -$6.7M +$163K +2.38% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-26
Q4 2012 -$21.1M -$4.1M +$5.47M +57.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-11
Q3 2012 -$26.6M -$5.92M -$10.4M -232% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 -$16.2M -$4.22M +$2.32M +35.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-11
Q1 2012 -$18.5M -$6.86M -$3.82M -125% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
Q4 2011 -$14.7M -$9.57M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-07
Q3 2011 $4.47M +$11.4M Jul 1, 2011 Sep 30, 2011 10-K 2013-03-07
Q2 2011 -$6.53M -$6.68M -4340% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-07
Q1 2011 -$3.05M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-07
Q3 2010 -$6.89M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $154K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.